Chen L, Zhang G, Li Q, Lin R. Variant Rs556621 on Chromosome 6p21.1 and the Risk of Ischemic Stroke in Chinese Populations: A Meta-Analysis.
Clin Appl Thromb Hemost 2022;
28:10760296221076479. [PMID:
35188813 PMCID:
PMC8864279 DOI:
10.1177/10760296221076479]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
There are inconsistencies in the published findings on the association of variant
rs556621 in an intergenic region on Chromosome 6p21.1 with the risk of
developing ischemic stroke (IS) and a major IS subtype (large artery
atherosclerosis, LAA) in Chinese populations. We conducted a meta-analysis to
evaluate the association of variant rs556621 with IS/LAA risk using ten studies
involving 3644 IS cases and 3692 controls (including seven studies involving
2268 LAA cases and 2268 controls) from China. The AA genotype increased IS risk
(AA versus CC: odds ratio [OR] 1.19, 95% confidence interval [CI] 1.03-1.36,
P = 0.015; AA versus CA + CC: OR 1.23, 95% CI 1.09-1.39,
P = 0.001). Subgroup analysis also suggested that rs556621
contributed to the risk of IS both in Chinese Han and the miscellaneous group.
However, these results were stable in Chinese Han but not in the miscellaneous
group. When restricting our analysis to the LAA subtype, similar results were
obtained. This meta-analysis is the first meta-analysis on the correlation
between rs556621 and the susceptibility of IS/LAA and demonstrates that rs556621
is associated with IS/LAA risk in Chinese populations. Further meta-analysis
warrants larger well-designed investigations to assess these effects.
Collapse